Suboxone

• Doctor Consultation
• Examination of your current and past medical history
• Treatment Plan
• Prescription: 2 weeks of medication (induction phase) sent directly to your local pharmacy)

After being stable on your medication for 2 weeks, you will graduate to the monthly maintenance phase.

• No. ELXR is a self-pay program.

• Suboxone is a medication commonly used in the treatment of opioid addiction, containing buprenorphine and naloxone. It is designed to reduce cravings and withdrawal symptoms associated with opioid dependence. Here's a list of typical candidates for Suboxone treatment:
• Individuals with a diagnosis of opioid use disorder (OUD) who are seeking treatment to manage their addiction.
• Those who have already undergone an initial detoxification phase and require ongoing medication-assisted treatment to maintain recovery.
• Patients for whom the benefits of Suboxone treatment outweigh the risks, such as potential for misuse, under the assessment of a healthcare professional.
• Individuals who are willing to follow a comprehensive treatment plan, which may include counseling and behavioral therapies alongside Suboxone medication.
• Patients who do not have any contraindicating medical conditions or medications that would make Suboxone use unsafe for them.
• People who have provided informed consent after being educated about the effects, potential side effects, and risks associated with Suboxone.
• In some cases, pregnant women with opioid use disorder may be candidates for Suboxone to reduce the risk of harm to themselves and their unborn child, under strict medical supervision

• Monthly Provider Visits
• Medication management 
• Ongoing support from the dedicated ELXR care team

• Use ELXR program's HIPAA and HITECH-compliant telehealth video platform for consultations.
• Instructions on using the system will be provided before your first visit.
• The platform is user-friendly and easy to navigate.
• Simple to use

FDA-approved to quickly counteract opioid overdoses. It is an opioid antagonist that reverses the effects of opioids like heroin. It's administered during overdose signs but is temporary, needing immediate medical follow-up. It can be delivered nasally, intramuscularly, subcutaneously, or intravenously. Prescribed for those at overdose risk, including long-term or rotating opioid users, post-emergency care patients, and those on specific opioid medications or recently abstinent.